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Introduction 
Since Leriche's classic paper in 1923 citing impotence 
as one of the first symptoms in men with aortoiliac 
occlusion, vascular surgeons have been interested in 
impotence. 1 Early operations for aortoiliac occlusive 
and aneurysmal disease often provoked postoperative 
impotence or other sexual disabilities further stimulat- 
ing interest in this area. 2 Techniques of aortic recon- 
struction ow minimise sexual disabilities by avoiding 
genital autonomic nerve injury and perfusing the 
internal iliac arteries; 3 these methods also correct 
impotence in certain cases. As a result of research on 
arteriogenic impotence, it was later discovered that 
pudendal and penile artery occlusion and cavernosal 
leakage also cause impotence. These dysfunctions can 
be corrected in some cases by microvascular 
operations. 
Corporal smooth muscle dysfunction also relates 
importantly to impotence, particularly in diabetes 
where impaired neurogenic and endothelium medi- 
ated relaxation are dominant factors. 4Table i classifies 
anatomic and functional causes of vasculogenic mpo- 
tence. The unique physiology of erection requires 
adequate arterial inflow and closure of venous out- 
flow, both mediated by neural mechanisms and by 
relaxation of the cavernous mooth muscle. Increased 
arterial inflow with cavernous mooth muscle relaxa- 
tion causes closure of venous outflow, and during 
erection, intracavernous pressure increases from 15 
mm Hg to levels ranging from 80 to 90 mm Hg. 5 
History and physical examination i  men with aorto- 
iliac disease reveal the usual prevalence and duration 
of risk factors for atherosclerosis, especially smoking, 
hypertension, hypercholesterolemia and more rarely 
diabetes. When absent femoral pulsations or an 
aneurysm are present, atherosclerosis nvolves the 
aortoiliac segments and sometimes proximal segments 
of the internal iliac artery. These findings indicate 
large vessel arteriogenic impotence and are indica- 
tions for reconstruction, ot for impotence per se but 
mainly related to the severity of claudication and 
aneurysm size. In screening over 1000 men, about 12 
to 147o with a chief complaint of impotence have 
Table 1. Causes of vasculogenic mpotence 
Arterial Large vessel: 
Small vessel: 
Cavernosal 
Factors 
Venous 
Combined: 
Arteriolar: 
Fibrosis: 
La Peyronie: 
Smooth muscle: 
Acquired: 
Congenital: 
Mixed: 
Aortoiliac occlusion 
Internal i iac anterior division, 
pudendal and penile arteries 
Atheroembolism: aneurysm 
or ulcerated aorta 
Functional or helicine artery 
abnormality 
Post-priapic, drug injection, 
ageing 
Deformity, cavernosal leakage 
Diabetes, hormonal lack, 
blood pressure medication 
Tunic albuginea bnormalities: 
patterns include dorsal vein, 
crural and spongiosum leaks 
Cavernous pongiosum leak 
existing since childhood 
Leakage with inadequate 
arterial inflow of any etiology 
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aortoiliac disease and about 1 in 100 has an occult 
aneurysm. 
Examination and testing for small vessel disease, 
venous leakage and cavernosal dysfunction are com- 
plex. Before these are done, the author recommends 
penile brachial indices (PBPI) and pulse volume 
recordings. 6 A penile brachial index of about 0.75 
suggests that no major occlusion exists between the 
aorta and the distal measurement point on the penis, 
while a PBPI of less than 0.6 suggests major vascular 
occlusion. Abnormal plethysmography can occur with 
either, but with normal indices, flat plethysmographic 
recordings are more often associated with small vessel 
disease. A sequence of neurovascular testing is useful 
preoperatively as neurologic disorders contribute to 
erectile failure. 6 About 28% of impotent men exhibit 
some type of neurologic disorder, elicited by testing of 
pudendal lumbar and cortical somatosensory evoked 
potentials. This usually contraindicates vascular 
reconstruction for impotence. Additionally 23% of 
men with the diagnosis of venous leakage actually 
have small vessel arterial occlusion, emphasising the 
need for dynamic infusion cavernosometry and cav- 
ernosography and selective pudendal arteriography 
before microvascular reconstruction. 7 
At the time of office examination, after initial 
neurovascular screening, it is useful to inject the 
corpora cavernosa with 10-30 micrograms of prosta- 
glandin E1 to observe the erectile response. Intra- 
corporal prostaglandin E 1 will often override fairly 
substantial arteriogenic impotence but may fail in 
severe cases of small vessel occlusion, cavernosal 
leakage, or refractory smooth muscle. Psychogenic 
factors also contribute to failure in the Office setting. 
Failure of erection after injection is an indication for 
invasive testing including cavernosometry, caverno- 
sography and measurement of cavernosal artery 
occlusion pressure. In the usual cases seen by the 
vascular surgeon, i.e., aortoiliac disease, standard 
arteriography with oblique views of the internal iliac 
arteries hould suffice. With more distal involvement, 
selective pudendal arteriography after penile injection 
of papaverine to produce tumescence, not full erection 
is needed to plan microvascular procedures. 
Treatment 
Medical treatment 
Before surgical intervention, cessation of smoking, 
control of hypercholesteremia and diabetes, and 
alteration of antihypertensive treatment by weight 
reduction or change in drug therapy should be tried. 
Some cases Of arteriogenic impotence respond to oral 
isoxsuprine 10-20 mg, 4 times a day. Yohimbine 
hydrochloride 5.4 mg. t.i.d, is also effective, though its 
mechanism of action is unknown. In the author's 
experience, 15-20% of men resume satisfactory erectile 
function with medical treatment. With the addition of 
self-injection of prostaglandin, medical treatment is 
applicable to most patients with vasculogenic impo- 
tence, provided aneurysmal disease is excluded. 
Surgical treatment 
Aortoiliac operations are done for conventional indi- 
cations i.e. claudication or aneurysms, using operative 
techniques to prevent sexual disability. These use 
dissection measures to preserve neural elements and 
highlight the importance of maintaining internal iliac 
flow. As stated by Dr Puech-Leao, the internal iliac 
artery should not become the "litter box" of the aorta. 
Internal iliac endarterectomy or bypass in conjunction 
with correction of aortoiliac disease is rewarding in 
selected cases. Prior to aneurysm repair, angiographic 
information about the anatomy of the internal iliacs 
helps plan methods to perfuse these arteries, prefera- 
bly in a prograde fashion. 
Procedures used occasionally for impotence 
include internal iliac endarterectomy, using an extrap- 
eritoneal approach. Penile microvascular surgery is 
suitable in about 5-6% of men presenting with 
impotence. The preferred inflow source is the inferior 
epigastric artery. The chances of success in penile 
microvascular surgery are best in young people with 
traumatic occlusion, e.g. pelvic fractures, or occlusive 
lesions of the pudendal artery at Alcock's canal. 
Arterialisation of the deep dorsal vein, using the 
inferior epigastric artery is useful when the penile 
arteries are atretic. The mechanism of this procedure is
not understood. With follow-ups longer than 12 
months, about half these men report spontaneous firm 
erections and about 70% achieve firm erections with 
intracavernous injections that were previously ineffec- 
tive. Furlow et al. reported on 156 men with 68% 
normal function following deep dorsal vein revascu- 
larisation with follow-up ranging from 6 months to 7.5 
years. 9Venous interruption procedures are similarly 
useful where dorsal vein leakage is dominant, s° About 
70%of these men become sensitive to intracavernous 
injections which previously failed. Other surgical 
options include penile prostheses which are indicated 
in men with neurologic or postoperative neurologic 
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abnormalities unresponsive to intracavernous injec- 
tion. Once a prosthesis is used, penile revascularisa- 
tion or intracavernous injections will not be possible. 
Conclusions 
Exciting progress in understanding the physiology of 
erectile function has occurred in the last 15 years. This 
field involves several disciplines, including urolog)5 
vascular surger)5 psychiatr)5 radiolog~ neurology and 
endocrinology. More precise testing capabilities, as 
well as intracavernous injections now make possible a 
quantitative delineation of abnormalities causing 
impotence. The vascular surgeon plays an important 
role in diagnosis and needs to be aware of diagnostic 
quantitative testing for erectile dysfunction. 6'8 In 
practice, operative techniques which minimise or 
prevent postoperative sexual dysfunction should be 
familiar to vascular surgeons along with a sensitivity 
to the presence of occult aneurysms in certain cases of 
impotence. 
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